blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3405785

EP3405785 - BIO-ANALYTICAL METHOD FOR INSULIN ANALOGUES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.03.2021
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  27.03.2020
FormerGrant of patent is intended
Status updated on  07.03.2020
FormerRequest for examination was made
Status updated on  26.02.2020
FormerGrant of patent is intended
Status updated on  04.11.2019
FormerRequest for examination was made
Status updated on  26.10.2018
FormerThe international publication has been made
Status updated on  28.07.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Biocon Limited
20th KM Hosur Road Electronic City
Bangalore 560 100 Karnataka / IN
[2019/49]
Former [2018/48]For all designated states
Biocon Limited
20th KM Hosur Road
Electronics City, P.O.
Karnataka
Bangalore 560100 / IN
Inventor(s)01 / BUDDHA, Madhavan
70, 3rd cross
Vishwapriya Layout
Karnataka Bangalore 560068 / IN
02 / PATALE, Mukesh, B.
Flat 711
park Golden Aura Apartment
TCP Layout
Hale Chandapura
Karnataka Bangalore 560081 / IN
03 / KHEDKAR, Anand
1F-101, Akme Harmony
Outer Ring Road
Bellandur
Karnataka Bangalore / IN
04 / TAGORE, Ranitendranath
C1303 Ajmera Infinity
89/1 Doddathogur Village
Begur Hobli
Electronic City
Karnataka Bangalore 560100 / IN
05 / MCDONALD, Sebastian, Alastair
29 Shirley Avenue
York North Yorkshire YO26 5NJ / GB
 [2020/18]
Former [2018/48]01 / BUDDHA, Madhavan
70 3rd cross
Vishwapriya Layout
Bangalore Karnataka 560068 / IN
02 / PATALE, Mukesh, B.
Flat 711
park Golden Aura Apartment
TCP Layout
Hale Chandapura
Bangalore Karnataka 560081 / IN
03 / KHEDKAR, Anand
1F-101
Akme Harmony
Outer Ring Road
Bellandur
Bangalore Karnataka / IN
04 / TAGORE, Ranitendranath
C1303 Ajmera Infinity
89/1 Doddathogur Village
Begur Hobli
Electronic City
Bangalore Karnataka 560100 / IN
05 / MCDONALD, Sebastian, Alastair
29 Shirley Avenue
York North Yorkshire YO26 5NJ / GB
Representative(s)Michalski Hüttermann & Partner Patentanwälte mbB
Kaistraße 16A
40221 Düsseldorf / DE
[N/P]
Former [2018/48]Michalski Hüttermann & Partner Patentanwälte mbB
Speditionstraße 21
40221 Düsseldorf / DE
Application number, filing date17741166.720.01.2017
[2018/48]
WO2017IB50303
Priority number, dateIN20164100261523.01.2016         Original published format: IN201641002615
[2018/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017125885
Date:27.07.2017
Language:EN
[2017/30]
Type: A1 Application with search report 
No.:EP3405785
Date:28.11.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 27.07.2017 takes the place of the publication of the European patent application.
[2018/48]
Type: B1 Patent specification 
No.:EP3405785
Date:29.04.2020
Language:EN
[2020/18]
Search report(s)International search report - published on:IN27.07.2017
(Supplementary) European search report - dispatched on:EP17.12.2018
ClassificationIPC:G01N33/00, G01N33/68, G01N33/74
[2019/48]
CPC:
G01N33/74 (EP,KR,US); C12P21/02 (US); G01N30/06 (KR);
G01N30/7233 (KR); G01N33/58 (KR); G01N33/6848 (EP,KR,US);
C12N2330/50 (US); C12N2503/02 (US); G01N2030/8831 (KR);
G01N2333/4745 (US); G01N2333/62 (EP,US); G01N2458/15 (KR,US);
Y10S930/022 (US) (-)
Former IPC [2018/48]G01N33/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/48]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:BIOANALYSEVERFAHREN FÜR INSULINANALOGA[2018/48]
English:BIO-ANALYTICAL METHOD FOR INSULIN ANALOGUES[2018/48]
French:PROCÉDÉ BIOANALYTIQUE POUR ANALOGUES D'INSULINE[2018/48]
Entry into regional phase08.08.2018National basic fee paid 
08.08.2018Search fee paid 
08.08.2018Designation fee(s) paid 
08.08.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
08.08.2018Amendment by applicant (claims and/or description)
08.08.2018Examination requested  [2018/48]
05.11.2019Communication of intention to grant the patent
24.02.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
24.02.2020Fee for grant paid
24.02.2020Fee for publishing/printing paid
06.03.2020Information about intention to grant a patent
06.03.2020Receipt of the translation of the claim(s)
Opposition(s)01.02.2021No opposition filed within time limit [2021/14]
Fees paidRenewal fee
29.01.2019Renewal fee patent year 03
16.01.2020Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.01.2017
AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
MK29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
LU20.01.2021
BE31.01.2021
[2024/22]
Former [2023/33]HU20.01.2017
AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
LU20.01.2021
BE31.01.2021
Former [2023/30]AL29.04.2020
AT29.04.2020
CY29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
LU20.01.2021
BE31.01.2021
Former [2022/33]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
LU20.01.2021
BE31.01.2021
Former [2021/43]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
LU20.01.2021
Former [2021/40]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
MC29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/24]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SI29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/10]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
NL29.04.2020
PL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SK29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/09]AL29.04.2020
AT29.04.2020
CZ29.04.2020
DK29.04.2020
EE29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
IT29.04.2020
LT29.04.2020
LV29.04.2020
NL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/08]AL29.04.2020
DK29.04.2020
ES29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
NL29.04.2020
RO29.04.2020
RS29.04.2020
SE29.04.2020
SM29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/04]AL29.04.2020
FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
NL29.04.2020
RS29.04.2020
SE29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2021/01]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RS29.04.2020
SE29.04.2020
BG29.07.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/51]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
RS29.04.2020
SE29.04.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/50]FI29.04.2020
HR29.04.2020
LT29.04.2020
LV29.04.2020
SE29.04.2020
NO29.07.2020
GR30.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/48]FI29.04.2020
LT29.04.2020
SE29.04.2020
NO29.07.2020
IS29.08.2020
PT31.08.2020
Former [2020/47]LT29.04.2020
NO29.07.2020
IS29.08.2020
Former [2020/46]IS29.08.2020
Documents cited:Search[A]KR20080067625  (BIOCON LTD [IN]) [A] 1-15 * abstract *;
 [A]US2014273044  (HELLERSTEIN MARC K [US]) [A] 1-15* [0052]-[0056]; [0075]-[0091] *;
 [AP]  - TAYLOR STEVEN W ET AL, "A high-throughput mass spectrometry assay to simultaneously measure intact insulin and C-peptide", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, (20160125), vol. 455, doi:10.1016/J.CCA.2016.01.019, ISSN 0009-8981, pages 202 - 208, XP029445214 [AP] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/j.cca.2016.01.019
International search[Y]US8058391  (DAVE NITESH [IN], et al) [Y] 2-3 * Full text *;
 [XY]  - RODRIGUEZ-CABALEIRO et al., "Pilot study for the standardization of insulin immunoassays with isotope dilution-liquid chromatography/tandem mass spectrometry", Clinical chemistry, (20070000), vol. 53, no. 8, pages 1462 - 1469, XP055402970 [X] 1 * Pages 1463-1464 Pages 1463-1464 * [Y] 2-4, 10

DOI:   http://dx.doi.org/10.1373/clinchem.2007.088393
 [Y]  - KIPPEN et al., "Development of an isotope dilution assay for precise determination of insulin, C-peptide, and proinsulin levels in non-diabetic and type II diabetic individuals with comparison to immunoassay", Journal of Biological Chemistry, (19970000), vol. 272, no. 19, pages 12513 - 12522, XP002272400 [Y] 2-4, 10 * Abstract, Page 12514 *

DOI:   http://dx.doi.org/10.1074/jbc.272.19.12513
 [A]  - THEVIS et al., "Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography tandem mass spectrometry for doping control purposes", Analytical chemistry, (20050000), vol. 77, no. 11, pages 3579 - 3585, XP055105086 [A] 1-19 * . Pages 3579 and 3582 *

DOI:   http://dx.doi.org/10.1021/ac050066i
 [A]  - STÖCKLIN et al., "A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry", Diabetes, (19970000), vol. 46, no. 1, doi:doi:10.2337/diabetes.46.1.44, pages 44 - 50, XP001036780 [A] 1-19 * . Page 45, Reaction design and methods *

DOI:   http://dx.doi.org/10.2337/diabetes.46.1.44
 [A]  - THEVIS et al., "Doping Control Analysis of Intact Rapid-Acting Insulin Analogues in Human Urine by Liquid Chromatography Tandem Mass Spectrometry", Analytical chemistry, (20060000), vol. 78, no. 6, pages 1897 - 1903, XP055105122 [A] 1-19 * . Pages 1897-1898 *

DOI:   http://dx.doi.org/10.1021/ac052095z
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.